comparemela.com

Latest Breaking News On - Anitan schmid - Page 1 : comparemela.com

Aadi Bioscience Announces Poster Presentations on Nab-Sirolimus at the International Gynecologic Cancer Society (IGCS) 2023 Annual Global Meeting

Aadi initiates Phase 2 trial investigating the combination of nab-sirolimus with letrozole for the treatment of advanced or recurrent endometrioid-type endometrial cancer LOS ANGELES, Oct. 19,.

Soult ukpyolsiSouth koreaAnitan schmidLinda duskaBrian slomovitzMarcy grahamWillish navarroCara mathewsLaurene dockeryKathleen mooreAnna priebeAadi bioscienceAllison puechlDavid omalleyFernanda musaPinternational gynecologic cancer society

Aadi Bioscience Announces Poster Presentations at 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

/PRNewswire/ Aadi Bioscience, Inc. (NASDAQ: AADI), a biopharmaceutical company focused on developing and commercializing precision therapies for patients.

United statesKhine nyein myintAadi bioscienceMaria zalathSean wallaceDavidj kwiatkowskiIgor vivancoCandace haddoxWillish navarroShihe houBrian mcmorranAndrew kwonJordi rodon ahnertNormaa palmaMichaelj demeureAnitan schmid

Aadi Bioscience Announces Poster Presentations at 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

LOS ANGELES, Sept. 20, 2023 /PRNewswire/ Aadi Bioscience, Inc. , a biopharmaceutical company focused on developing and commercializing precision therapies for patients with mTOR pathway.

United statesShihe houBrian mcmorranWillish navarroAndrew kwonNormaa palmaMichaelj demeureJordi rodon ahnertAnitan schmidGopa iyerAadi bioscienceKhine nyein myintMaria zalathSean wallaceDavidj kwiatkowskiMarcy graham

vimarsana © 2020. All Rights Reserved.